[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA979937B - Delayed delivery system for acid-sensitive drugs - Google Patents

Delayed delivery system for acid-sensitive drugs

Info

Publication number
ZA979937B
ZA979937B ZA979937A ZA979937A ZA979937B ZA 979937 B ZA979937 B ZA 979937B ZA 979937 A ZA979937 A ZA 979937A ZA 979937 A ZA979937 A ZA 979937A ZA 979937 B ZA979937 B ZA 979937B
Authority
ZA
South Africa
Prior art keywords
delivery system
acid
barrier
omeprazole
pulsatile
Prior art date
Application number
ZA979937A
Other languages
English (en)
Inventor
Vinay K Sharma
Original Assignee
Sharmatek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sharmatek Inc filed Critical Sharmatek Inc
Publication of ZA979937B publication Critical patent/ZA979937B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
ZA979937A 1996-11-06 1997-11-05 Delayed delivery system for acid-sensitive drugs ZA979937B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74098196A 1996-11-06 1996-11-06

Publications (1)

Publication Number Publication Date
ZA979937B true ZA979937B (en) 1999-05-18

Family

ID=24978866

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA979937A ZA979937B (en) 1996-11-06 1997-11-05 Delayed delivery system for acid-sensitive drugs

Country Status (7)

Country Link
EP (1) EP0941074B1 (xx)
AT (1) ATE271379T1 (xx)
AU (1) AU5179898A (xx)
DE (1) DE69729950T2 (xx)
NO (1) NO992186D0 (xx)
WO (1) WO1998019668A1 (xx)
ZA (1) ZA979937B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774288B1 (fr) * 1998-01-30 2001-09-07 Ethypharm Sa Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
FR2793688B1 (fr) 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
SE9902386D0 (sv) * 1999-06-22 1999-06-22 Astra Ab New formulation
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
ATE297194T1 (de) * 1999-12-16 2005-06-15 Medinfar Produtos Farmaceutico Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
WO2003037244A2 (en) 2001-10-29 2003-05-08 Therics, Inc. System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
WO2004080439A1 (ja) 2003-03-12 2004-09-23 Takeda Pharmaceutical Company Limited 高濃度に活性成分を球形核に付着させた医薬組成物
CA2547398A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP1720527A2 (en) * 2004-03-03 2006-11-15 Teva Pharmaceutical Industries Ltd A stable pharmaceutical composition comprising an acid labile drug
JP2008502740A (ja) * 2004-06-15 2008-01-31 テバ ファーマシューティカル インダストリーズ リミティド ベンズイミダゾール化合物の安定医薬製剤
AR051654A1 (es) * 2004-11-04 2007-01-31 Astrazeneca Ab Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
AR052225A1 (es) * 2004-11-04 2007-03-07 Astrazeneca Ab Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
JP2009503020A (ja) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 肥満症の治療におけるフリバンセリンの使用
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
CN101389317A (zh) * 2005-12-28 2009-03-18 武田药品工业株式会社 控制释放固体制剂
KR20080081071A (ko) * 2005-12-28 2008-09-05 다케다 야쿠힌 고교 가부시키가이샤 방출 제어 고형 제제
JP2009541443A (ja) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁及び関連疾患の治療のためのフリバンセリン
AU2007286288A1 (en) 2006-08-14 2008-02-21 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
BRPI0716436B8 (pt) * 2006-08-25 2021-05-25 Boehringer Ingelheim Int sistema de liberação controlada e método para fabricação do mesmo
JP5799299B2 (ja) 2007-02-01 2015-10-21 ザ・アイムス・カンパニーＴｈｅ Ｉａｍｓ Ｃｏｍｐａｎｙ ブドウ糖代謝拮抗物質、アボカド又はアボカド抽出物を使用する、哺乳動物における炎症及びストレスの低下方法
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
WO2009113090A2 (en) * 2008-01-17 2009-09-17 Alkem Laboratories Ltd. Process for preparing an oral formulation of an acid-sensitive benzimidazole drug
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
UA41946C2 (uk) * 1994-07-08 2001-10-15 Астра Актієболаг Оральна фармацевтична складова одинична дозована форма у вигляді таблетки, спосіб її одержання, упаковка у вигляді блістера та спосіб інгібування секреції шлункової кислоти і/або лікування шлунково-кишкових запальних захворювань

Also Published As

Publication number Publication date
ATE271379T1 (de) 2004-08-15
NO992186L (no) 1999-05-05
EP0941074B1 (en) 2004-07-21
EP0941074A1 (en) 1999-09-15
AU5179898A (en) 1998-05-29
DE69729950D1 (de) 2004-08-26
NO992186D0 (no) 1999-05-05
WO1998019668A1 (en) 1998-05-14
DE69729950T2 (de) 2005-07-28

Similar Documents

Publication Publication Date Title
ZA979937B (en) Delayed delivery system for acid-sensitive drugs
EP0670718B1 (en) Pulsatile particles drug delivery system
US6761895B2 (en) Drug delivery system for averting pharmacokinetic drug interaction and method thereof
AU1488295A (en) Pharmaceutical composition
NZ237516A (en) Device for drug delivery to intestinal tract comprising a core of active ingredient together with osmotically activated expulsion agent and an outer coating containing a hydrophobic material to assist in delaying release
DE60021604D1 (de) Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben
EP1207860A1 (en) Controlled release pellet formulation
MX9500885A (es) Preparacion farmaceutica para administracion oral.
NO20003640L (no) Ny doseringsform
MXPA01003197A (es) Suministro enterico y colonico utilizando capsulas de chpm.
CA2144094A1 (en) Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
SI9520049A (en) Controlled-release dosage forms of azithromycin
WO2000003696A1 (en) Enteric coated pharmaceutical tablet and method of manufacturing
NO982302L (no) Farmas°ytisk sammensetning
US5824341A (en) Composition providing selective release of an active ingredient
MXPA05001243A (es) Formulacion de lamotrigina de liberacion prolongada y uso de la misma para su preparacion.
EP1217992A1 (en) Coated solid dosage forms
AU736357B2 (en) Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient
JPH0624959A (ja) 胃内浮遊型薬物徐放性固形製剤
KR20220113697A (ko) 알칼리제 및 장용성 코팅층을 포함하는 투여 형태
WO2001078681A1 (fr) Systeme d'administration de medicament empechant l'interaction pharmacocinetique entre les medicaments et procede correspondant
AU2009247712B2 (en) Compositions and methods for inhibiting gastric acid secretion
EP4013401A1 (en) Articles and methods for administration of therapeutic agents
US6074669A (en) Controlled drug delivery system for diltiazem
WO2004041244A2 (en) Oral extended release tablets and methods of making and using the same